| Active substance |
Peptide |
| Also known as |
AICA riboside, Acadesine |
| Blood pressure |
No significant effects reported |
| Chemical name |
5-Aminoimidazole-4-carboxamide ribonucleotide |
| Dosage (medical) |
Not specified for human therapeutic use |
| Dosage (sports) |
50-100 mg per day |
| Effects |
Increases glucose uptake in skeletal muscle tissue, endurance enhancement |
| Formula |
C9H15N4O8P |
| Half-life |
2-3 hours |
| Hepatotoxicity |
Low |
| Lab Test |
Detection through specific blood tests |
| Main action |
AMP-activated protein kinase activator |
| Side effects |
Potential risk of cancer, may affect blood flow and nutrient delivery |
| Storage conditions |
Store at room temperature, protect from light |
| Substance class |
Nucleotide |
| Trade name |
Not commercially marketed as a therapeutic drug |
| Use in sports |
Banned under the World Anti-Doping Agency (WADA) for use in competitive sports |
| Water Retention |
None |
| Active ingredient, mg |
50 |
| Release form |
Vial |
| 1 Vial, ml |
10 |
| Vials in the package, pcs |
5 |
| Manufacturer |
Peptide Sciences |
| Packing |
Packing (5 bottles), Vial |
